Jason Wittes

Stock Analyst at Roth MKM

(3.06)
# 1,245
Out of 4,873 analysts
62
Total ratings
48.15%
Success rate
0.1%
Average return

Stocks Rated by Jason Wittes

Stryker
May 2, 2025
Maintains: Buy
Price Target: $405$456
Current: $379.16
Upside: +20.27%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.41
Upside: +563.90%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4$5.4
Current: $2.80
Upside: +92.86%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15$16
Current: $1.71
Upside: +835.67%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $10.80
Upside: +103.80%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60$72
Current: $59.50
Upside: +21.02%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.29
Upside: +107.94%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100$115
Current: $57.81
Upside: +98.93%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.65
Upside: +441.76%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.45
Upside: +70.54%
Initiates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Reinstates: Buy
Price Target: $100
Current: $83.38
Upside: +19.93%
Reiterates: Buy
Price Target: $5
Current: $2.11
Upside: +136.97%
Initiates: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
Initiates: Buy
Price Target: $75
Current: $29.96
Upside: +150.33%
Initiates: Buy
Price Target: $22
Current: $10.86
Upside: +102.58%
Initiates: Neutral
Price Target: $120
Current: $91.50
Upside: +31.15%
Initiates: Buy
Price Target: $206
Current: $168.22
Upside: +22.46%
Reinstates: Buy
Price Target: $145
Current: $221.34
Upside: -34.49%
Initiates: Buy
Price Target: $15
Current: $11.49
Upside: +30.55%
Initiates: Buy
Price Target: $200
Current: $16.61
Upside: +1,104.09%
Initiates: Buy
Price Target: $26
Current: $36.56
Upside: -28.88%